USE OF NEW CARBON CLUSTER FULLERENES AS ANTIOXIDANTS IN PROTEIN STORAGE COMPOUNDS USED IN STROKE PREVENTION
Abstract
As you know, ischemic brain damage is increasing all over the world. According to the WHO, cardiovascular disease (CVD) is the leading cause of death worldwide. 17.5 million people die from CVD every year.
References
Semenov K. N. et al. Development of Graphene-Based Materials with the Targeted Action for Cancer Theranostics //Biochemistry (Moscow). – 2024. – Т. 89. – №. 8. – С. 1362-1391.
Yusupova S. S., Kholmurodova D. K., Kiyamova D. S. Vexibia Alopecroides-How to New Source for the Synthesis of Physiologically Active Substances Used in Medicine //Global Scientific Review. – 2023. – Т. 20. – С. 25-30.
Kumar P., Kholmurodova D. K. Digitalization of laboratory diagnostics. – 2022.
Рахманова Ф. Э., Холмуродова Д. К. Применение оксида азота для антимикробных, ранозаживляющих кожных лечебных мазей //international scientific review of the problems of natural sciences and medicine. – 2022. – С. 8-20.
Kholmurodova D. K., Semyonov K. N., Mokhammad S. Use of new carbon cluster fullerenes as antioxidants in protein storage compounds used in stroke prevention //Биотехнология и биомедицинская инженерия. – 2022. – С. 227-229.
Kodirov, B., Rayimkulova, C., Kholmurodova, D., & Turgunov, D. (2024, November). Silicon carbide synthesis in a solar oven from natural raw materials. In E3S Web of Conferences (Vol. 508, p. 01005). EDP Sciences.
Kholmurodova, D., Kiyamova, D., Rakhmonova, F., & Bakhromova, B. (2024, November). Study of the process of obtaining fuel briquettes from production waste. In E3S Web of Conferences (Vol. 508, p. 07008). EDP Sciences.
Kholmurodova D. K., The use of hts in folk medicine //Academia Repository. – 2023. – Т. 4. – №. 10. – С. 69-73.
Раимкулова Ч. А., Холмуродова Д. К. Разработка методов и устройств для неинвазивного контроля некоторых клинически значимых биомаркеров //журнал гепато-гастроэнтерологических исследований. – 2022. – №. SI-2.
Kumar P., Kholmurodova D. K. Digitalization of laboratory diagnostics. – 2022.
Semenov, K. N., Prokopiev, I. A., Petukhova, N. V., Kremenetskaya, U. A., Senichkina, D. A., Epifanovskaya, O. S., ... & Sharoyko, V. V. (2024). Atranorin is a novel potential candidate drug for treating myelodysplastic syndrome. Journal of Molecular Liquids, 413, 125743.
